Patent · US Expired

Methods and compositions for selectin inhibition

US7465798B2 · kind B2 · utility

0Cited by
2References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2004
Grant dateDec 16, 2008
Priority date
Expiry dateApr 24, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I:wherein the constituent variables are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.